Search Results

There are 17988 results for: content related to: Amyloid deposition, hypometabolism, and longitudinal cognitive decline

  1. An Improved Model for Disease Progression in Patients From the Alzheimer's Disease Neuroimaging Initiative

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 629–644, Dr Mahesh N. Samtani, Dr Michael Farnum, Dr Victor Lobanov, Dr Eric Yang, Dr Nandini Raghavan, Dr Allitia DiBernardo, Dr Vaibhav Narayan and And the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011405497

  2. You have free access to this content
    Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

    British Journal of Clinical Pharmacology

    Volume 75, Issue 1, January 2013, Pages: 146–161, Mahesh N. Samtani, Nandini Raghavan, Yingqi Shi, Gerald Novak, Michael Farnum, Victor Lobanov, Tim Schultz, Eric Yang, Allitia DiBernardo, Vaibhav A. Narayan and the Alzheimer' s Disease Neuroimaging Initiative

    Version of Record online : 14 DEC 2012, DOI: 10.1111/j.1365-2125.2012.04308.x

  3. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease

    Human Brain Mapping

    Volume 36, Issue 6, June 2015, Pages: 2093–2117, Xiaoying Tang, Dominic Holland, Anders M. Dale, Laurent Younes, Michael I. Miller and for the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 3 FEB 2015, DOI: 10.1002/hbm.22758

  4. You have full text access to this OnlineOpen article
    Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNI

    CPT: Pharmacometrics & Systems Pharmacology

    Volume 2, Issue 10, October 2013, Pages: 1–10, I Delor, J-E Charoin, R Gieschke, S Retout, P Jacqmin and For the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 2 OCT 2013, DOI: 10.1038/psp.2013.54

  5. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer's disease biomarker related cognitive decline?

    European Journal of Neurology

    Volume 23, Issue 5, May 2016, Pages: 948–957, B. S. Ye, W. W. Lee, J. H. Ham, J. J. Lee, P. H. Lee, Y. H. Sohn and for the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 24 FEB 2016, DOI: 10.1111/ene.12969

  6. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease

    International Journal of Geriatric Psychiatry

    Volume 27, Issue 1, January 2012, Pages: 15–21, Ralf Ihl, Steven Ferris, Philippe Robert, Bengt Winblad, Serge Gauthier and Frank Tennigkeit

    Version of Record online : 8 MAR 2011, DOI: 10.1002/gps.2679

  7. Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry

    Human Brain Mapping

    Volume 31, Issue 4, April 2010, Pages: 499–514, April J. Ho, Xue Hua, Suh Lee, Alex D. Leow, Igor Yanovsky, Boris Gutman, Ivo D. Dinov, Natasha Leporé, Jason L. Stein, Arthur W. Toga, Clifford R. Jack Jr., Matt A. Bernstein, Eric M. Reiman, Danielle J. Harvey, John Kornak, Norbert Schuff, Gene E. Alexander, Michael W. Weiner, Paul M. Thompson and the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 24 SEP 2009, DOI: 10.1002/hbm.20882

  8. You have free access to this content
    Rivastigmine for Alzheimer's disease

    Intervention Review

    The Cochrane Library

    Jacqueline S Birks, Lee Yee Chong and John Grimley Evans

    Published Online : 22 SEP 2015, DOI: 10.1002/14651858.CD001191.pub4

  9. You have full text access to this OnlineOpen article
    Biomarkers and cognitive endpoints to optimize trials in Alzheimer's disease

    Annals of Clinical and Translational Neurology

    Volume 2, Issue 5, May 2015, Pages: 534–547, Philip S. Insel, Niklas Mattsson, R. Scott Mackin, John Kornak, Rachel Nosheny, Duygu Tosun-Turgut, Michael C. Donohue, Paul S. Aisen, Michael W. Weiner and Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 21 MAR 2015, DOI: 10.1002/acn3.192

  10. Renal function affects hippocampal volume and cognition: The role of vascular burden and amyloid deposition

    Geriatrics & Gerontology International

    Hoyoung An, Booyeol Choi, Sang Joon Son, Eun Young Cho, Seon-Ok Kim, Sooyun Cho, Duk-Hee Kang, Chul Lee, Seong Yoon Kim and for the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 22 FEB 2017, DOI: 10.1111/ggi.12985

  11. You have free access to this content
    Statins for the treatment of dementia

    Intervention Review

    The Cochrane Library

    Bernadette McGuinness, David Craig, Roger Bullock, Reem Malouf and Peter Passmore

    Published Online : 8 JUL 2014, DOI: 10.1002/14651858.CD007514.pub3

  12. Three sides of the same coin: measuring global cognitive impairment with the MMSE, ADAS-cog and CAMCOG

    International Journal of Geriatric Psychiatry

    Volume 25, Issue 8, August 2010, Pages: 770–779, Hans Wouters, Willem A. van Gool, Ben Schmand, Aeilko H. Zwinderman and Robert Lindeboom

    Version of Record online : 27 NOV 2009, DOI: 10.1002/gps.2402

  13. Noncognitive Disturbances in Alzheimer's Disease: Frequency, Longitudinal Course, and Relationship to Cognitive Symptoms

    Journal of the American Geriatrics Society

    Volume 45, Issue 11, November 1997, Pages: 1331–1338, Deborah B. Marin, Cynthia R. Green, James Schmeidler, Philip D. Harvey, Brian A. Lawlor, Theresa M. Ryan, Mohsen Aryan, Kenneth L. Davis and Richard C. Mohs

    Version of Record online : 27 APR 2015, DOI: 10.1111/j.1532-5415.1997.tb02932.x

  14. Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale–cognitive subscale: domain and individual item analysis

    International Journal of Geriatric Psychiatry

    Volume 29, Issue 9, September 2014, Pages: 920–927, Gustavo Alva, Richard Isaacson, Carl Sadowsky, George Grossberg, Xiangyi Meng and Monique Somogyi

    Version of Record online : 18 FEB 2014, DOI: 10.1002/gps.4080

  15. Galantamine for Alzheimer's disease and mild cognitive impairment

    Intervention Review

    The Cochrane Library

    Clement Loy and Lon Schneider

    Published Online : 25 JAN 2006, DOI: 10.1002/14651858.CD001747.pub3

  16. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response

    Acta Neurologica Scandinavica

    Volume 129, Issue 2, February 2014, Pages: 114–122, A. Karin, K. Hannesdottir, J. Jaeger, P. Annas, M. Segerdahl, P. Karlsson, N. Sjögren, T. von Rosen and F. Miller

    Version of Record online : 13 JUN 2013, DOI: 10.1111/ane.12153

  17. The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer’s disease

    Acta Neurologica Scandinavica

    Volume 121, Issue 3, March 2010, Pages: 186–193, E. H. Wiig, P. Annas, H. Basun, N. Andreasen, L. Lannfelt, H. Zetterberg, K. Blennow and L. Minthon

    Version of Record online : 24 SEP 2009, DOI: 10.1111/j.1600-0404.2009.01160.x

  18. You have free access to this content
    Touch Panel-type Dementia Assessment Scale: a new computer-based rating scale for Alzheimer's disease

    Psychogeriatrics

    Volume 11, Issue 1, March 2011, Pages: 28–33, Masashi INOUE, Daiki JIMBO, Miyako TANIGUCHI and Katsuya URAKAMI

    Version of Record online : 25 FEB 2011, DOI: 10.1111/j.1479-8301.2010.00345.x

  19. Rationale for Combination Therapy With Galantamine and Memantine in Alzheimer's Disease

    The Journal of Clinical Pharmacology

    Volume 46, Issue S1, July 2006, Pages: 17S–26S, Dr George T. Grossberg, Dr Keith R. Edwards and Dr Qinying Zhao

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006288735

  20. You have full text access to this OnlineOpen article
    Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

    EMBO Molecular Medicine

    Volume 8, Issue 10, October 2016, Pages: 1184–1196, Niklas Mattsson, Philip S Insel, Sebastian Palmqvist, Erik Portelius, Henrik Zetterberg, Michael Weiner, Kaj Blennow, Oskar Hansson and for the Alzheimer's Disease Neuroimaging Initiative

    Version of Record online : 17 AUG 2016, DOI: 10.15252/emmm.201606540